Gabapentin Dosing Guidelines
Starting Dose
- Initiate gabapentin at 100 mg – 300 mg once nightly or 100 mg – 300 mg three times daily; lower initial doses are recommended for older adults to reduce early‑onset dizziness and sedation. 1
Titration Schedule
- Increase the dose by 100 mg – 300 mg every 1–7 days as tolerated, aiming for a gradual escalation that balances efficacy with side‑effect risk. 4
- The titration phase typically requires 3–8 weeks to reach the maximum tolerated dose. 6
Target Therapeutic Dose
- An effective maintenance range is 1800 mg – 3600 mg per day, divided into three doses; most patients achieve pain relief at 1800 mg/day (600 mg three times daily), while higher doses may be needed for refractory pain, though benefits above 1800 mg are not consistently demonstrated. 1
Duration of an Adequate Trial
- Allow 3–8 weeks of titration plus an additional 2 weeks at the highest tolerated dose before declaring treatment failure. 2
- In practice, a full therapeutic trial may extend to 2 months or longer to capture delayed response. 3
Renal‑Impairment Dose Adjustments (mandatory due to renal excretion)
| Creatinine Clearance (CrCl) | Recommended Daily Dose (divided) | Comments |
|---|---|---|
| ≥ 60 mL/min | 900 – 3600 mg in three divided doses | Standard adult dosing |
| 30 – 59 mL/min | 400 – 1400 mg in two divided doses | Reduce proportionally |
| 15 – 29 mL/min | 200 – 700 mg as a single daily dose | Further reduction |
| < 15 mL/min | 100 – 300 mg as a single daily dose | Severe renal failure |
| Hemodialysis | Maintenance dose per CrCl + post‑dialysis supplement of 125 – 350 mg after each 4‑hour session | Adjust for dialysis clearance |
*These adjustments are based on the pharmacokinetic requirement to avoid drug accumulation in renal insufficiency. 4
Pharmacokinetic Rationale
- Gabapentin displays non‑linear, dose‑dependent absorption because intestinal transport becomes saturated at higher single doses; consequently, three‑times‑daily dosing optimizes bioavailability. 4
Safety Considerations (Common Pitfalls)
- Renal function must be assessed before initiating therapy; failure to adjust dosing in renal impairment leads to drug accumulation and heightened adverse‑effect risk. 1
- Elderly patients should undergo slower titration to minimize dizziness and sedation, which are more prevalent with rapid dose escalation. 7
Tolerability Management
- The most frequent adverse effects are dose‑related dizziness and sedation; starting at the lower end of the dosing range and titrating cautiously reduces their incidence. 7
- If these side effects emerge, slow the titration rate rather than discontinuing therapy, as symptoms are often transient and improve with dose adjustment. 1